In IBD patients, the mechanisms involved in the process of oral tolerance are also defective, with low mucosal levels of the anti-inflammatory cytokine, IL-10, leading to the maturation of dendritic cells and the stimulation of Th1 pro-inflammatory responses [102,103]. This evidence concerns the gene IL10 and inflammatory bowel disease.